A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
Public ClinicalTrials.gov record NCT00902291. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Global, Multi-center, Open-label, Phase 2 Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
Study identification
- NCT ID
- NCT00902291
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Astellas Pharma Inc
- Industry
- Enrollment
- 205 participants
Conditions and interventions
Interventions
- AGS-1C4D4 Biological
- Gemcitabine Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2009
- Primary completion
- Mar 31, 2012
- Completion
- Mar 31, 2012
- Last update posted
- Sep 13, 2015
2009 – 2012
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Diego Medical Center | La Jolla | California | 92093 | — |
| Palm Beach Institute of Hematology and Oncology | Boynton Beach | Florida | 33435 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Medical Oncology LLC | Baton Rouge | Louisiana | 70809 | — |
| Annapolis Oncology Center | Annapolis | Maryland | 21401 | — |
| Dana Farber Cancer Center | Boston | Massachusetts | 02115 | — |
| Virginia G. Piper Cancer Center | Minneapolis | Minnesota | 55407 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | — |
| Regional Oncology Center | Syracuse | New York | 13210 | — |
| Kaiser Permanente Northwest Region Oncology Hematology | Portland | Oregon | 97227 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29605 | — |
| Baptist Regional Cancer Center | Knoxville | Tennessee | 37920 | — |
| Vanderbilt University Medical Center, Div. of Medical Oncology | Nashville | Tennessee | 37232 | — |
| Alan B. Pearson Regional Cancer Center Lynchburg Hematology Oncology Clinic | Lynchburg | Virginia | 24501 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00902291, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 13, 2015 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00902291 live on ClinicalTrials.gov.